Primary Job Title Managing Director Primary Organization 
NewSpring Ventures
Location Philadelphia, Pennsylvania, United States Regions Greater Philadelphia Area, Great Lakes, Northeastern US Gender Male
Investor Type
LinkedIn View on LinkedIn
Michael DiPiano is a General Partner of NewSpring Ventures and the Managing Partner of NewSpring Capital. Prior to joining NewSpring Capital, Michael DiPiano was a serial entrepreneur and investor. He led or co-led the investment into six companies in the business services, healthcare and information technology industries. During that time, he
was affiliated with Safeguard Scientifics (NYSE:SFG) and their related Funds. Prior to 1996, he spent six years as a division CEO and director of Chemical Leaman Corporation. Michael DiPiano started his career in 1980 with Baxter Healthcare Corporation (NYSE: BAX) where he held numerous positions culminating as Vice President responsible for Operations and Sales of the Industrial Scientific Products Division.
He currently serves on the boards of Femme Pharma; the Mid-Atlantic Capital Alliance, formerly known as the Greater Philadelphia Venture Group, which is a trade association representing over 80 Mid-Atlantic based private equity funds with approximately $12 billion under management, where he served as the 2005 program year Chairman; NutriSystem (NASDAQ: NTRI); Prescient Applied Intelligences (OTC BB: PPID); Bluenog; and the University City Science Center, where he sits on the investment committee.
